Aziz-Ur Rehman
Financieel Directeur/CFO bij GOLDEN AGE EXPLORATION LTD.
Profiel
Aziz-Ur Rehman is currently working as a Controller at KOP Therapeutics Corp.
and as a Chief Financial Officer at Golden Age Exploration Ltd.
He previously worked as a Chief Financial Officer & Director at AEL Textiles Ltd.
and as an Accountant at Hampsom Equities Ltd.
from 2016 to 2019.
Mr. Rehman completed his undergraduate degree from Athabasca University.
Actieve functies van Aziz-Ur Rehman
| Bedrijven | Functie | Begin |
|---|---|---|
| GOLDEN AGE EXPLORATION LTD. | Financieel Directeur/CFO | 11-01-2022 |
KOP Therapeutics Corp.
 KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | Comptroller/Controller/Auditor | 01-02-2021 |
Eerdere bekende functies van Aziz-Ur Rehman
| Bedrijven | Functie | Einde |
|---|---|---|
| Hampsom Equities Ltd. | Comptroller/Controller/Auditor | 01-03-2019 |
| AEL TEXTILES LIMITED | Financieel Directeur/CFO | - |
Opleiding van Aziz-Ur Rehman
| Athabasca University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GOLDEN AGE EXPLORATION LTD. | Non-Energy Minerals |
| Bedrijven in privébezit | 3 |
|---|---|
AEL Textiles Ltd.
 AEL Textiles Ltd. Alternative Power GenerationUtilities AEL Textiles Ltd. engages in dealing and trading of textile products and materials. The company was founded on February 20, 1994 and is headquartered in Lahore, Pakistan. | Utilities |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | Health Technology |
| Hampsom Equities Ltd. |